Skip to main content
logo
AP Biosciences, Inc. (TPEX:6945)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
88.80
-2.10 (-2.31%)
Jul 29, 2026, 1:30 PM CST

AP Biosciences Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---32.25-6.99
Revenue Growth
------94.92%
Gross Profit
---32.25-6.99
Operating Income
-471.51-456.38-439.06-347.48-297.5-186.72
Net Income
-459.05-444.77-422.75-339.3-288.54-187.61
Earnings Per Share
-5.38-5.23-5.61-5.24-5.48-7.78
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0971,1711,542740.021,079557.12
Total Debt
56.6359.5170.9182.08--
Net Cash (Debt)
1,0401,1111,471657.941,079557.12
Net Cash Growth
-29.27%-24.43%123.54%-39.01%93.62%-11.67%
Net Cash Per Share
12.2013.0619.5310.1620.4923.10

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-362.54-352.09-357.88-297.62-275.97-168.68
Capital Expenditures
-23.3-25.03-5.53-35.03-1.13-3.9
Free Cash Flow
-385.84-377.12-363.41-332.65-277.1-172.58
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%-100.00%
Operating Margin
----1077.35%--2670.06%
Pretax Margin
----1051.98%--2682.77%
Profit Margin
----1051.98%--2682.77%
FCF Margin
----1031.37%--2467.90%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---93.55--